intravitreal anti-vascular endothelial development element usage in France throughout COVID-19 pandemic
What The Research study Did: This research study measured modifications in making use of intravitreal (IVT) anti-vascular endothelial development aspects (anti-VEGF), the primary treatment for retinal vascular problems, given that the COVID-19 pandemic began in France.
Authors: Sophie Billioti de Gage, Pharm.D., P.D., of EPI-PHARE, French National Company for Medicines and Health Products Security, French National Medical Insurance in Saint-Denis, France, is the matching author.
To access the embargoed research study: Check Out our For The Media site at this link https:/
( doi:10.1001/ jamaophthalmol.2020.5594)
Editor’s Note: Please see the short article for extra info, consisting of other authors, author contributions and associations, dispute of interest and monetary disclosures, and financing and assistance.
###
Media advisory: The complete research study is connected to this press release.
Embed this link to supply your readers open door to the full-text short article This link will be live at the embargo time https:/
Disclaimer: AAAS and EurekAlert! are not accountable for the precision of press release published to EurekAlert! by contributing organizations or for making use of any info through the EurekAlert system.
